Sleep Disordered Breathing in Primary Care
Diagnosis, PAP Management & Emerging Therapies
- Speaker:
- Jill Fritz, MSN, ANP-BC
- Duration:
- 2 Hours 07 Minutes
- Format:
- Audio and Video
- Copyright:
-
Jun 05, 2026
- Product Code:
- POS078995
- Media Type:
- Digital Seminar
Description
- Take ownership of OSA in your practice — screen, diagnose, manage PAP, and know when to refer
- GLP-1s and OSA: learn how the diagnosis changes your prescribing approach and how to adjust as patients lose weight
- When treated patients are still exhausted: a systematic approach from polypharmacy review to the latest pharmacology
Sleep apnea diagnoses are rising, specialist wait times are growing, and patients are falling through the cracks. Primary care clinicians are increasingly the first - and sometimes only - point of contact for patients with obstructive sleep apnea, yet many feel underprepared to independently manage them. This program changes that.
Gain a practical, confident approach to screening, diagnosing, and managing sleep-disordered breathing without defaulting to a specialty referral. Learn how to troubleshoot the most common PAP barriers that derail patient adherence and explore the expanding role of GLP-1 therapies in OSA management, including prescriptive considerations specific to an OSA diagnosis. For patients who remain excessively sleepy despite treatment, discover a systematic approach to next-step evaluation, from polypharmacy review to targeted pharmacologic options. You'll also get an up-to-the-minute look at what's in the pharmaceutical pipeline, including trials investigating novel combination therapies that may reshape how OSA is treated in the coming years.
Credit
Speaker
Jill Fritz, MSN, ANP-BC Related seminars and products
Jill Fritz, MSN, ANP-BC, is a nurse practitioner with over 20 years of clinical experience in sleep medicine and pulmonology. She pioneered an initiative to improve PAP therapy compliance by reviewing sleep study results with patients directly in the sleep laboratory following testing, and has led the development of a GLP-1 program at her clinic to support patients with obstructive sleep apnea and obesity, integrating emerging therapies into practical care models. She is committed to empowering primary care clinicians to confidently recognize and manage sleep-disordered breathing in everyday practice.
Speaker Disclosures:
Financial: Jill Fritz has an employment relationship with Ferrell Duncan Pulmonology and previously received a consulting fee from Tegus. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Jill Fritz is a fellow of the Association of Pulmonary Advanced Practice Providers and a member of the Advance Practice Nurses of the Ozarks.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Evaluate screening tools to support diagnosis of obstructive sleep apnea in the primary care setting.
- Discover how to troubleshoot common PAP problems and roadblocks that lead to decreased patient adherence to treatment.
- Analyze prescriptive differences for GLP-1 therapy related to an OSA diagnosis.
- Determine appropriate treatment options other than PAP, with therapy tailored to the specific patient.
Outline
The OSA Epidemic: Why Primary Care Clinicians Must Be Part of the Solution
- Prevalence trends and the growing specialist shortage
- OSA as a cardiac risk modifier: what's at stake for your patients
- Screening tools and diagnostic pathways for the primary care setting
PAP Therapy: Initiating, Managing, and Troubleshooting
- Starting patients on PAP with confidence
- Troubleshooting the most common adherence barriers: pressure intolerance, mask fit, humidity
- Reviewing PAP data and knowing when to escalate
GLP-1 Therapies and OSA: What the Evidence Shows
- SURMOUNT-OSA trial results and clinical implications
- Dosing, side effects, and patient selection
- Managing PAP therapy as patients lose weight: when to adjust, when to discontinue
Persistent Sleepiness Despite Treatment: A Systematic Approach
- Medication list review: identifying polypharmacy contributors to daytime fatigue
- Ruling out other untreated conditions driving hypersomnia
- AASM Practice Parameters for adjunct medical therapy
- Pharmacology toolkit: modafinil, armodafinil, solriamfetol - indications and differences
The Pharmacology Pipeline: What's Coming for OSA
- LunAIRo/SynAIRgy trials: oxybutynin/atomoxetine combination therapy
- RePOSA trial: IHL-42X (dronabinol/acetazolamide)
- EXPLORE-OSA: lorundrostat
- What these mean for primary care prescribers
Target Audience
- Physicians
- Physician Assistants
- Nurses
- Nurse Practitioners
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...